Search results
May 5, 2023 · In a new study, Yale scientists have identified the immune signature of rare cases of myocarditis among those vaccinated against COVID-19 with mRNA vaccines.
Jul 28, 2023 · Analyzing over 100 000 patients with heart failure, no safety concerns were found regarding the risk of all-cause mortality, worsening heart failure, myocarditis, or venous thromboembolism in patients with heart failure vaccinated with any of the SARS-CoV-2 mRNA vaccines.
SARS-CoV-2 infection increases the risk of major adverse cardiac events (MACE) and long-term cardiovascular sequelae after recovery. 1 However, the association of vaccination on cardiovascular outcomes following infection has not been elucidated in the United States.
May 13, 2024 · The TTE examination in our study showed that the entire group of patients who developed cardiac discomfort after vaccine administration presented with a normal LVEF, a traditional indicator for...
Feb 8, 2023 · Our study showed that myocarditis was the most reported post-COVID19 vaccination cardiac event. All reported cardiac events including myocarditis, TTC, MI, and VITT occurred most frequently after receiving mRNA vaccines (Moderna & Pfizer-BioNTech).
- 10.1016/j.hrtlng.2023.02.003
- May-June 2023
- Heart Lung. 2023 May-June; 59: 173-180.
Feb 9, 2022 · COVID-19 vaccines using mRNA technology do not produce any extra short-term side effects in cancer patients, a new study suggests.
Jan 3, 2023 · The current systematic review and meta-analysis showed that the IR of cardiac arrhythmia post-COVID-19 vaccination is rare and ranges between 1 and 76 per 10,000. mRNA vaccines, including Moderna and Pfizer, were associated with a higher IR of arrhythmia than vector-based vaccines.
